Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Indoor Rowing in Adults With Impaired Glucose Regulation: a Pilot Study
Primary research question: What is the effect of indoor rowing, under the ideal
circumstances of a laboratory setting, on glucose control in adults with impaired glucose
control?
Secondary research question: Is it possible to develop a full-scale study of the benefits of
indoor rowing under the usual circumstances of a community setting?
Why? It is good practice to conduct a small pilot study before embarking on an expensive
full-scale study.
What? Around 150 minutes of aerobic exercise and around 150 minutes of resistance exercise
per week are necessary to meet prevailing recommendations for adults with impaired glucose
control. Around 120 minutes of indoor rowing per week might be a less time-consuming
alternative to prevailing recommendations because indoor rowing involves a combination of
aerobic and resistance exercise.
Who? Twenty men and postmenopausal women aged 45-65 years with impaired glucose regulation,
such as those with type 2 diabetes. Eligible volunteers will not have smoked in the last
year, will not have exercised regularly in the last six months, and will not be taking any
form of diabetes medication other than metformin. Eligible volunteers will have stable
weight and a body mass index of 25-40.
Where and how? Before and after the exercise intervention, glucose control (postprandial
blood glucose concentrations) will be assessed at Leicester Diabetes Centre and cardiac
function (MRI) will be assessed at Glenfield Hospital. During the exercise intervention,
participants will use an indoor rower three times per week for 12 weeks at Leicester
Diabetes Centre. Participants will be taught how to row correctly and the duration and
intensity will gradually increase. In order to inform the design of a full-scale trial,
recruitment rate will be assessed, adherence will be monitored, and a third party will
interview participants to find out if the intervention and assessments are feasible and
acceptable.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |